Health Chinook Therapeutics to Present at Upcoming Investor Conferences James Pereira Apr 12, 2023 <!-- Name:DistributionId Value:8803101 --> <!--… Read More...
Health Chinook Therapeutics Announces Upcoming Presentations at the 5th Chronic Kidney Disease Drug… James Pereira Feb 28, 2023 <!-- Name:DistributionId Value:8777971 --> <!--… Read More...
Health Chinook Therapeutics to Present at Upcoming Investor Conferences James Pereira Nov 23, 2022 SEATTLE, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company… Read More...
LifeStyle MEDIA ALERT: B-ROLL & PHOTO OPPORTUNITY : ATHLETA TO CELEBRATE CF CHINOOK CENTRE OPENING… Taner Halicioglu Nov 1, 2022 Calgary, AB, Nov. 01, 2022 (GLOBE NEWSWIRE) -- WHAT: This week, Athleta welcomed its new CF Chinook Centre store… Read More...
LifeStyle Chinook Seedery Partners with Bobby Witt Jr. To Release Their Newest Flavor Taner Halicioglu Oct 26, 2022 Bobby Witt Jr. partners with Chinook Seedery on new flavor… Read More...
Business Chinook Therapeutics Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Nick J Adam Aug 5, 2022 SEATTLE, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company… Read More...
Health Chinook Therapeutics Presents Data from Atrasentan Phase 2 AFFINITY IgA Nephropathy (IgAN) Patient… James Pereira May 20, 2022 The AFFINITY IgAN cohort of 20 patients is fully enrolled, with 70% of patients in the study having baseline… Read More...
Health Chinook Therapeutics Presents Updated Data from BION-1301 Phase 1/2 Trial in Patients with IgA… James Pereira May 19, 2022 All patients with IgAN in Cohort 1 have transitioned to subcutaneous (SC) dosing, and BION-1301 remains well-tolerated,… Read More...
Health Chinook Therapeutics Announces Upcoming Data Presentations and Investor Conference Call at the 59th … James Pereira May 2, 2022 Data on atrasentan to be presented in an oral presentation from the IgA nephropathy (IgAN) patient cohort of the phase… Read More...
Health Chinook Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference James Pereira Apr 6, 2022 SEATTLE, April 05, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company… Read More...